6V1H

Crystal structure of the bromodomain of human BRD7 bound to bromosporine


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.93 Å
  • R-Value Free: 0.235 
  • R-Value Work: 0.201 
  • R-Value Observed: 0.203 

Starting Model: experimental
View more details

wwPDB Validation   3D Report Full Report

Currently 6V1H does not have a validation slider image.


This is version 1.2 of the entry. See complete history


Literature

Structural Basis of Inhibitor Selectivity in the BRD7/9 Subfamily of Bromodomains.

Karim, R.M.Chan, A.Zhu, J.Y.Schonbrunn, E.

(2020) J Med Chem 63: 3227-3237

  • DOI: https://doi.org/10.1021/acs.jmedchem.9b01980
  • Primary Citation of Related Structures:  
    6PPA, 6UZF, 6V0Q, 6V0S, 6V0U, 6V0X, 6V14, 6V16, 6V17, 6V1B, 6V1E, 6V1F, 6V1H, 6V1K, 6V1L, 6V1U

  • PubMed Abstract: 

    Inhibition of the bromodomain containing protein 9 (BRD9) by small molecules is an attractive strategy to target mutated SWI/SNF chromatin-remodeling complexes in cancer. However, reported BRD9 inhibitors also inhibit the closely related bromodomain-containing protein 7 (BRD7), which has different biological functions. The structural basis for differential potency and selectivity of BRD9 inhibitors is largely unknown because of the lack of structural information on BRD7. Here, we biochemically and structurally characterized diverse inhibitors with varying degrees of potency and selectivity for BRD9 over BRD7. Novel cocrystal structures of BRD7 liganded with new and previously reported inhibitors of five different chemical scaffolds were determined alongside BRD9 and BRD4. We also report the discovery of first-in-class dual bromodomain-kinase inhibitors outside the bromodomain and extraterminal family targeting BRD7 and BRD9. Combined, the data provide a new framework for the development of BRD7/9 inhibitors with improved selectivity or additional polypharmacologic properties.


  • Organizational Affiliation

    Department of Drug Discovery, Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, Florida 33612, United States.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Bromodomain-containing protein 7126Homo sapiensMutation(s): 0 
Gene Names: BRD7BP75CELTIX1
UniProt & NIH Common Fund Data Resources
Find proteins for Q9NPI1 (Homo sapiens)
Explore Q9NPI1 
Go to UniProtKB:  Q9NPI1
PHAROS:  Q9NPI1
GTEx:  ENSG00000166164 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ9NPI1
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Ligands 2 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
BMF (Subject of Investigation/LOI)
Query on BMF

Download Ideal Coordinates CCD File 
B [auth A]Bromosporine
C17 H20 N6 O4 S
UYBRROMMFMPJAN-UHFFFAOYSA-N
EDO
Query on EDO

Download Ideal Coordinates CCD File 
C [auth A]1,2-ETHANEDIOL
C2 H6 O2
LYCAIKOWRPUZTN-UHFFFAOYSA-N
Binding Affinity Annotations 
IDSourceBinding Affinity
BMF BindingDB:  6V1H Kd: 392 (nM) from 1 assay(s)
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.93 Å
  • R-Value Free: 0.235 
  • R-Value Work: 0.201 
  • R-Value Observed: 0.203 
  • Space Group: C 2 2 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 71.43α = 90
b = 109.02β = 90
c = 36.9γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
XSCALEdata scaling
PDB_EXTRACTdata extraction
XDSdata reduction
PHASERphasing

Structure Validation

View Full Validation Report

Currently 6V1H does not have a validation slider image.



Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2020-03-11
    Type: Initial release
  • Version 1.1: 2020-04-08
    Changes: Database references
  • Version 1.2: 2023-10-11
    Changes: Data collection, Database references, Refinement description